Related Experiment Video
Updated: Jun 27, 2026
10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Dilated Cardiomyopathy.
1Division of Cardiology, Heart-Lung Research Institute, The Ohio State University Medical Center, 473 West 12th Avenue, Room 261, Columbus, OH 43210, USA. Leier.1@osu.edu
Current Treatment Options in Cardiovascular Medicine
|November 7, 2001
Summary
Managing dilated cardiomyopathy (DCM) heart failure involves diagnosing the cause, assessing heart function, and treating complications. Treatment includes medications, devices like biventricular pacing, and lifestyle changes for optimal patient outcomes.
Area of Science:
- Cardiology
- Heart Failure Management
Background:
- Dilated cardiomyopathy (DCM) is a complex heart condition requiring comprehensive management.
- Effective treatment necessitates understanding hemodynamic characteristics and identifying complicating factors.
Purpose of the Study:
- To outline the diagnostic and therapeutic strategies for managing patients with dilated cardiomyopathy (DCM) heart failure.
- To detail pharmacological, interventional, and non-pharmacological approaches in DCM management.
Main Methods:
- Initial assessment includes diagnosis, hemodynamic characterization, and identification of complicating factors or surgically remedial lesions.
- Pharmacological therapy involves angiotensin-converting enzyme inhibitors, beta-blockers, digoxin, diuretics, and spironolactone.
- Advanced therapies include biventricular pacing (cardiac resynchronization therapy) and, for end-stage disease, mechanical devices and transplantation.
Main Results:
- Pharmacological agents like ACE inhibitors and beta-blockers are foundational for symptomatic DCM.
- Spironolactone shows efficacy in advanced heart failure stages.
- Cardiac resynchronization therapy is indicated for specific DCM patients with conduction defects.
Conclusions:
- A multi-faceted approach combining pharmacotherapy, device therapy, and non-pharmacological interventions is crucial for DCM management.
- Dedicated heart failure programs are essential for delivering comprehensive care, including dietary and exercise recommendations.
Related Concept Videos
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...